C. Christiansen

发表

Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types

M. Karsdal, J. Erler, J. Aerts, 2022, Cellular and Molecular Life Sciences.

Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women

J. Risteli, C. Hassager, Claus Christiansen, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker

M. Karsdal, K. Duffin, L. Rasmussen, 2012, Journal of Translational Medicine.

Measurement of Bone Degradation Products in Serum Using Antibodies Reactive with an Isomerized Form of an 8 Amino Acid Sequence of the C‐Telopeptide of Type I Collagen

C. Christiansen, P. Delmas, P. Qvist, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases

Claus Christiansen, László B. Tankó, Kim Henriksen, 2007, Osteoporosis International.

Bone gla protein (osteocalcin) assay standardization report

C. Christiansen, K. Mann, P. Delmas, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Value of biomarkers in osteoarthritis: current status and perspectives

C. Cooper, C. Christiansen, O. Bruyère, 2013, Annals of the rheumatic diseases.

Matrix metalloproteinases (MMPs) safeguard osteoblasts from apoptosis during transdifferentiation into osteocytes: MT1-MMP maintains osteocyte viability.

M. Karsdal, C. Christiansen, L. Bonewald, 2004, DNA and cell biology.

Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies.

C. Christiansen, P. Qvist, N. Bjarnason, 1995, Clinical chemistry.

Immunoassay for quantifying type I collagen degradation products in urine evaluated.

C. Christiansen, P. Qvist, C. Fledelius, 1994, Clinical chemistry.

Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.

C. Christiansen, P. Alexandersen, P. Qvist, 1998, Clinical chemistry.

Two-dimensional gel analysis of human endometrial proteins: characterization of proteins with increased expression in hyperplasia and adenocarcinoma.

C. Christiansen, M. Larsen, S. Fey, 1999, Molecular human reproduction.

Should subchondral bone turnover be targeted when treating osteoarthritis?

K Henriksen, M. Karsdal, C. Christiansen, 2008, Osteoarthritis and cartilage.

Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover.

C. Christiansen, L. Arendt-Nielsen, H. C. Hoeck, 2014, Osteoarthritis and cartilage.

Biochemical markers and the FDA Critical Path: How biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development

M. Karsdal, C. Christiansen, E. Dam, 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.

C. Christiansen, P. Qvist, C. Fledelius, 1998, Clinical chemistry.

Cohort Profile: The Prospective Epidemiological Risk Factor (PERF) study.

M. Karsdal, C. Christiansen, P. Alexandersen, 2016, International journal of epidemiology.

Republished: Value of biomarkers in osteoarthritis: current status and perspectives

C. Cooper, M. Karsdal, C. Christiansen, 2013, Postgraduate Medical Journal.

Role of biochemical markers in the management of osteoporosis

M. Karsdal, C. Christiansen, K. Henriksen, 2015, Climacteric : the journal of the International Menopause Society.

Use of Bone Turnover Markers in Clinical Osteoporosis Assessment in Women: Current Issues and Future Options

M. Karsdal, C. Christiansen, K. Henriksen, 2011, Women's health.

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting.

C. Christiansen, P. Qvist, S. Christgau, 2002, Bone.

Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension

M. Karsdal, C. Christiansen, J. Trebicka, 2013, Alimentary pharmacology & therapeutics.

Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA?

M. Karsdal, C. Christiansen, L. Tankó, 2006, Osteoarthritis and cartilage.

Automated detection of hypoglycemia-induced EEG changes recorded by subcutaneous electrodes in subjects with type 1 diabetes--the brain as a biosensor.

Jens Juul Holst, J. Holst, K. Højlund, 2010, Diabetes research and clinical practice.

Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women

M. Karsdal, C. Christiansen, H. B. Hansen, 2016, Medicine.

Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes.

M. Karsdal, C. Christiansen, L. Tankó, 2006, Osteoarthritis and cartilage.

Advances in osteoclast biology resulting from the study of osteopetrotic mutations

M. Karsdal, C. Christiansen, J. Bollerslev, 2008, Human Genetics.

Osteoarthritis--a case for personalized health care?

K Henriksen, M. Karsdal, C. Christiansen, 2014, Osteoarthritis and cartilage.

Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies

M. Karsdal, C. Christiansen, P. Qvist, 2008, Osteoporosis International.

Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.

M. Karsdal, C. Christiansen, E. Dam, 2009, Osteoarthritis and cartilage.

Oral Salmon Calcitonin Improves Fasting and Postprandial Glycemic Control in Lean Healthy Rats

M. Karsdal, C. Christiansen, K. Henriksen, 2011, Hormone and Metabolic Research.

An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage

M. Karsdal, C. Christiansen, L. Tankó, 2008, Climacteric : the journal of the International Menopause Society.

Osteoarthritis--a case for personalized health care?

M. Karsdal, V. Kraus, C. Ladel, 2014, Osteoarthritis and cartilage.